BPC
SAGE icon

Banque Pictet & Cie’s Sage Therapeutics SAGE Stock Holding History

Banque Pictet & Cie’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-20,223
Closed -$849K – 588
2023
Q1 		$849K Buy
20,223
+207
+1% +$8.9K 0.01% 401
2022
Q4 		$763K Sell
20,016
-6,316
-24% -$241K 0.01% 438
2022
Q3 		$1.03M Buy
+26,332
New +$1.02M 0.01% 392

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Banque Pictet & Cie's SAGE Position: Q2 2023 in Review

Banque Pictet & Cie sold out of Sage Therapeutics (SAGE) in Q2 2023, closing a stake of 20,223 shares — an estimated $849K sold.

Banque Pictet & Cie first reported a position in SAGE in Q3 2022 and held it in 3 quarters. The position peaked at $1.03M in Q3 2022. 225 funds tracked by Wall St. Rank hold SAGE as of Q2 2023.

  • Banque Pictet & Cie reported no remaining Sage Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Banque Pictet & Cie sold 20,223 Sage Therapeutics shares in Q2 2023, an estimated $849K.
  • Banque Pictet & Cie first reported a position in Sage Therapeutics in Q3 2022 and held it in 3 quarters.
  • Banque Pictet & Cie's Sage Therapeutics position peaked at $1.03M in Q3 2022.
  • 225 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2023.

Based on Banque Pictet & Cie's 13F filing for Q2 2023, filed 4 Aug 2023.